Physician profile
Mark E Oppenlander
NPI 1033373998
$74,764.09
in general payments reported to CMS, 2019-2025
17 companies · $6,950 in 2025
The $6,950 reported for 2025 was more than what 83% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $16K · 2021: $14K · 2022: $9,925 · 2023: $8,648 · 2024: $4,512 · 2025: $6,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,463 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $3,928 · Travel and Lodging: $2,584 · Royalty Or License: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,462.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $3,927.63 |
| Travel and Lodging | $2,584.29 |
| Royalty Or License | $635.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $53,493.86 | 2019-2025 | Excelsius Gps, Durapro, Excelsiusgps Robotic Navigation System |
| Bioventus LLC | $13,048.66 | 2021-2024 | Bonescalpel |
| Medical Device Business Services, INC. | $2,925.00 | 2019-2022 | |
| Alphatec Spine, INC | $2,358.47 | 2023 | Other - Miscellaneous, Solus Alif, Battalion Tlif - PC |
| Medtronic, INC. | $949.87 | 2023-2025 | Catalyft Pl Expandable Interbody System, Unid_pass, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Nuvasive, INC. | $604.11 | 2022-2023 | Modulus, Alif, Xlif |
| Nevro Corp. | $302.20 | 2022-2023 | Senza |
| Sanara Medtech INC. | $289.52 | 2023-2025 | Celleraterx, Celleraterx |
| Abbott Laboratories | $247.72 | 2025 | Proclaim, Penta |
| Depuy Synthes Sales INC. | $203.72 | 2019 | |
| Titan Spine, LLC | $134.01 | 2019 | |
| Medicrea USA, Corp. | $126.95 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $50.00 | 2023 | Kinevo 900 |
| Carl Zeiss Meditec, INC. | $15.15 | 2019 | |
| Kuros Biosciences USA, INC | $14.85 | 2025 | Magnetos |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Oppenlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.